Quick Answer
Altamira Therapeutics Ltd. reported Gross Profit of -$1.14 million for the year ending 2022.
- Altamira Therapeutics Ltd. showed an increase of +47.7% in Gross Profit from 2021 to 2022.
- This data is from Altamira Therapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on May 16, 2023.
- XBRL data for this metric is available from 2021 to 2022 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2022: -$1.14 million | Fiscal year 2021: -$2.18 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: